Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded revision v3.3.4 and removed revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's Locations section was updated to include a full list of study sites across the U.S. (Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, New Jersey, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Washington) and Canada (Alberta, Ontario, Quebec) with Revision: v3.3.3. The previous location blocks were removed and the HHS Vulnerability Disclosure section was deleted (transitioning from v3.3.2 to v3.3.3).SummaryDifference2%

- Check46 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1; this appears to be a minor internal update with no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedThe Publications section now clarifies that entries are automatically filled from PubMed and may not all pertain to the study, and a Revision: v3.3.1 tag was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the global government funding/operating status notice from the page, a general site-wide message not related to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check75 days agoChange DetectedOnly minor layout and formatting adjustments were observed on the Study Details page, with core study data such as inclusion criteria, primary outcomes, and enrollment remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.